These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8366982)

  • 1. Pattern of hyperlipoproteinemia in human nephrotic syndrome: influence of renal failure and diabetes mellitus.
    Joven J; Villabona C; Vilella E
    Nephron; 1993; 64(4):565-9. PubMed ID: 8366982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-density lipoproteins in untreated idiopathic nephrotic syndrome without renal failure.
    Joven J; Rubiés-Prat J; Espinel E; Ras MR; Piera L
    Nephrol Dial Transplant; 1987; 2(3):149-53. PubMed ID: 3114674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of hyperlipidemia in the nephrotic syndrome.
    Attman PO; Alaupovic P
    Am J Nephrol; 1990; 10 Suppl 1():69-75. PubMed ID: 2256478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
    Breier C; Lisch HJ; Drexel H; Braunsteiner H
    Schweiz Med Wochenschr; 1983 Jun; 113(25):909-13. PubMed ID: 6612272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
    Joven J; Villabona C; Vilella E; Masana L; Albertí R; Vallés M
    N Engl J Med; 1990 Aug; 323(9):579-84. PubMed ID: 2381443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apoproteins in dyslipoproteinemia (author's transl)].
    Dewailly P
    Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E phenotype and hyperlipoproteinemia in nephrotic syndrome.
    Lerique B; Moulin B; Delpéro C; Purgus R; Olmer M; Boyer J
    Clin Chem; 1994 May; 40(5):849-50. PubMed ID: 8174269
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe hyperlipoproteinemia in congenital nephrotic syndrome of the Finnish type: effect of dialysis and kidney transplantation.
    Salo MK; Jaakkola O; Solakivi T; Ylä-Herttuala S
    Acta Paediatr; 1993 Sep; 82(9):768-72. PubMed ID: 8241675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catabolism of very low density lipoproteins in experimental nephrosis.
    Garber DW; Gottlieb BA; Marsh JB; Sparks CE
    J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus.
    Suzaki K; Kobori S; Ueno S; Uehara M; Kayashima T; Takeda H; Fukuda S; Takahashi K; Nakamura N; Uzawa H
    Atherosclerosis; 1990 Jan; 80(3):181-9. PubMed ID: 2310424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of lipids, lipoproteins, and apolipoproteins in Menkes' disease.
    Blackett PR; Lee DM; Donaldson DL; Fesmire JD; Chan WY; Holcombe JH; Rennert OM
    Pediatr Res; 1984 Sep; 18(9):864-70. PubMed ID: 6483510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipids status in patients with diabetic uremia on 10 years of maintenance hemodialysis.
    Sakurai T; Akiyama H; Oka T; Sekita K; Yokono K; Goto T
    Kidney Int Suppl; 1999 Jul; 71():S216-8. PubMed ID: 10412780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High density lipoprotein cholesterol in secondary hyperlipoproteinemias].
    Titov VN; Tvorogova MG; Kantardzhian IG; Alamdarova IA; Negovskaia AV
    Lab Delo; 1983; (12):11-7. PubMed ID: 6201650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in serum lipoproteins in kidney diseases].
    Mordasini R; Riesen W
    Schweiz Med Wochenschr; 1982 Sep; 112(39):1335-40. PubMed ID: 6755693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compositional lipoprotein changes and low-density lipoprotein susceptibility to oxidation in chronic renal failure patients with heavy proteinuria.
    Karabina SA; Pappas H; Miltiadous G; Bairaktari E; Christides D; Tselepis A; Elisaf M; Siamopoulos K
    Nephron Clin Pract; 2003; 95(3):c77-83. PubMed ID: 14646367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotic syndrome associated with hyper-high-density lipoproteinemia potentiated by prednisolone therapy.
    Sasaki J; Hara F; Motooka T; Naito S; Arakawa K
    Nephron; 1985; 41(1):110-3. PubMed ID: 3929150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyslipoproteinaemia in Nigerians with the nephrotic syndrome (an increased risk for ischaemic heart disease?).
    Erasmus RT; Arije A; Uyot C
    Cent Afr J Med; 1990 Aug; 36(8):195-8. PubMed ID: 2282650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis.
    Marsh JB; Sparks CE
    J Clin Invest; 1979 Nov; 64(5):1229-37. PubMed ID: 227928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.